Ursprung des Netzwerks ersten Grades von Michael Zhang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Cambridge
278
| College/University | Other Consumer Services | 278 |
Deutsche Bank AG (Broker UK)
 Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Deutsche Bank AG (Deutsche Bank UK) is the UK-based securities brokerage division of Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in London and was founded in 1873. Deutsche Bank provides brokerage services to companies and institutions.
130
| Operating Division | Investment Banks/Brokers | 130 |
JNE Partners LLP
 JNE Partners LLP Investment ManagersFinance JNE Partners LLP is the Great Britain-based investment management subsidiary of JNE Partners (UK) Services Ltd. (JNE Partners UK). Formerly known as MSD Partners Europe LLP, the firm changed their name into JNE Partners LLP in 2019 after their former parent firm MSD Capital (UK) Ltd. sold its ownership stakes into JNE Partners UK. Headquartered in London, JNE Partners was founded in 2009 and is a spin out from MSD Partners LP, the investment firm formed by the partners of MSD Capital LP, which exclusively manages the assets of Michael S. Dell and his family.
7
| Subsidiary | Investment Managers | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Zhang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Oxford | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Birmingham | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Inflexion Private Equity Partners LLP
 Inflexion Private Equity Partners LLP Investment ManagersFinance Inflexion Private Equity Partners LLP (Inflexion Private Equity Partners) is a private equity firm founded in 1999 by John Frederick Hartz and Simon Eric Hugh Turner. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Delhi | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Leeds | College/University | Graduate Degree Undergraduate Degree | |
| University College London | College/University | Doctorate Degree Graduate Degree | |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
BII Group Ltd.
 BII Group Ltd. Investment ManagersFinance BII Group Ltd. (BII Group) is a private equity/venture capital, a subsidiary of Government of United Kingdom was founded by James Murray Grant in 1948. The firm is headquartered in London with offices in Bengaluru, Mumbai, Nairobi, Pakistan, Sandton, and Bangladesh. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Corporate Officer/Principal Private Equity Investor | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| King's College London | College/University | Doctorate Degree Graduate Degree | |
| UBS GROUP AG | Investment Managers | Corporate Officer/Principal Private Equity Analyst | |
| CANTABIO PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
ECI Partners LLP
 ECI Partners LLP Investment ManagersFinance ECI Partners LLP (ECI Partners) is a private equity founded in 1976. The firm is headquartered in London, the United Kingdom with an additional offices in Manchester and New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Cambridge Judge Business School | College/University | Graduate Degree Masters Business Admin | |
| Leaps By Bayer /US/ | Investment Managers | Private Equity Investor | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
Cue learn Pvt Ltd.
 Cue learn Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Cue learn Pvt Ltd. provides educational services. Its programs are designed to have a significant and demonstrable improvements in learning outcomes. The company was founded by Manan Khurma and Jagjit Khurma in 2011 and is headquartered in New Delhi, India. | Miscellaneous Commercial Services | Director/Board Member | |
Google UK Ltd.
 Google UK Ltd. Internet Software/ServicesTechnology Services Part of Alphabet, Inc., Google UK Ltd. is a company that operates as an internet portal and search index website. Google UK Ltd. is based in London, UK. | Internet Software/Services | Sales & Marketing | |
Bd-Capital Partners Ltd. (United Kingdom)
 Bd-Capital Partners Ltd. (United Kingdom) Investment ManagersFinance Bd-Capital Partners Ltd. (Bd-Capital Partners) is a private equity firm founded in 2019 by Richard Baker and Andy Dawson. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst | |
Atomico (UK) Partners LLP
 Atomico (UK) Partners LLP Investment ManagersFinance Atomico (UK) Partners LLP (Atomico (UK) Partners) is a venture capital firm founded in 2006 by Mattias Ljungman and Niklas Mårten Zennström. The firm is headquartered in London, United Kinghdom with additional offices in Sau Paulo and New York. | Investment Managers | Private Equity Investor | |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Symprove Ltd.
 Symprove Ltd. Food RetailRetail Trade Symprove Ltd. is a British company that offers a unique gut health supplement called Daily Essential, which contains billions of live and active bacteria for gut support. The company is based in Farnham, UK and was founded in 2002 by Barry Smith and Barry Edward Smith. The product comes in three different flavors and is gluten and dairy-free. With over 100K happy customers, Symprove's scientifically proven product is known to boost beneficial bacteria and improve gut health. Mike Butler has been the CEO of the company since 2010. | Food Retail | Director/Board Member | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Lansdowne Partners (UK) LLP
 Lansdowne Partners (UK) LLP Investment ManagersFinance Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| AZITRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amira Learning, Inc.
 Amira Learning, Inc. Packaged SoftwareTechnology Services Amira Learning, Inc. develops learning to read software. The company was founded by Mark A. Angel and Pete Jungwirth and is headquartered in Las Vegas, CA. | Packaged Software | Consultant / Advisor | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Green Investment Group Management Ltd.
 Green Investment Group Management Ltd. Investment ManagersFinance Green Investment Group Management Ltd. (Green Investment) is a Private Equity firm, a subsidiary of UK Green Investment Bank Ltd. founded in 2012. The firm is headquartered in Edinburgh, United Kingdom. | Investment Managers | Private Equity Investor | |
| Bayes Business School | College/University | Undergraduate Degree | |
| Università degli Studi di Napoli Federico II | College/University | Undergraduate Degree | |
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Director/Board Member | |
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sheffield Asset Management LLC
 Sheffield Asset Management LLC Investment ManagersFinance Sheffield Asset Management LLC (Sheffield) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Chicago, Illinois. The firm was founded by Brian Feltzin in 2003. Sheffield serves as the investment manager for and provides discretionary investment advisory services to a private investment fund which is offered to outside investors. Investors generally consist of institutions, family offices, fund of funds, high net worth individuals and trusts. | Investment Managers | Analyst-Equity | |
| Rutgers State University of New Jersey | College/University | Graduate Degree | |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor | |
Netwookie Ltd.
 Netwookie Ltd. Internet Software/ServicesTechnology Services Netwookie Ltd. provides online platform services for drivers. The British company was founded by Maximilian Bock. | Internet Software/Services | Chief Executive Officer | |
| Madanyu Ltd. | Chief Executive Officer | ||
Beyondnetzero
 Beyondnetzero Investment ManagersFinance Beyondnetzero (BNZ) is a private equity firm, a subsidiary of General Atlantic LLC founded in 2021 by Lance Darrell Gordon Uggla and Lord John Browne. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Riverside Management Group LLC (Venture Capital)
 Riverside Management Group LLC (Venture Capital) Investment ManagersFinance Riverside Management Group LLC (Venture Capital) (Riverside Management Group) is a venture capital/private equity division of Riverside Management Group LLC founded in 1996 by D James Carpenter, Mark A. Bernegger, and Christopher Robin Wood. The firm is headquartered in Westport, CT. | Investment Managers | Private Equity Investor | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 26 |
| Vereinigte Staaten | 19 |
| Indien | 3 |
| Italien | 3 |
| Deutschland | 3 |
Sektoral
| Finance | 18 |
| Consumer Services | 14 |
| Health Technology | 11 |
| Commercial Services | 6 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 98 |
| Undergraduate Degree | 74 |
| Private Equity Investor | 61 |
| Graduate Degree | 58 |
| Corporate Officer/Principal | 42 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Anshu Jain | 22 |
| Lucio Iannone | 17 |
| David Douglas Cleevely | 14 |
| Thomas Sawyer | 13 |
| Christopher Kelly | 12 |
| Sam Hall | 12 |
| Rahul Vohra | 12 |
| Li Fan | 11 |
| Tim Funnell | 10 |
| Jane Jin | 10 |
| Deviyani Godwin | 9 |
| Samuel Bjork | 8 |
| Jonty Roland | 8 |
| Ken Aseme | 8 |
| Yi Liu | 7 |
- Börse
- Insiders
- Michael Zhang
- Unternehmensverbindungen
